CanaQuest Medical Corp

International CBD Life Science R&D Excellence Award 2020
Winners image
<p>Two IP-protected products, Mentanine® and Mentabinol®, cannabinoid molecules to address mental health issues &#8211; ready for commercialization as non-Rx (non-prescription drugs).</p> <p>Primary goal is to sell pharmaceutical products (Rx), upon receipt of regulatory approvals from the U.S. FDA and Health Canada. Products are past pre-clinical phase &#8211; focus Epilepsy.</p> <p>Product formulations are owned by the company and developed through a research agreement with Western University. Patents have been filed.</p>